Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 19 | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | cytochrome P450, family 3, subfamily A, polypeptide 4 | Starlite/ChEMBL | No references |
Homo sapiens | cytochrome P450, family 1, subfamily A, polypeptide 2 | Starlite/ChEMBL | No references |
Homo sapiens | polymerase (DNA directed), beta | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Leishmania major | cytochrome p450-like protein | cytochrome P450, family 2, subfamily C, polypeptide 19 | 490 aa | 411 aa | 23.1 % |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | polymerase (DNA directed), beta | 335 aa | 303 aa | 32.3 % |
Brugia malayi | Cytochrome P450 family protein | cytochrome P450, family 1, subfamily A, polypeptide 2 | 516 aa | 470 aa | 26.2 % |
Brugia malayi | cytochrome P450 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 502 aa | 492 aa | 24.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | Nicastrin, putative | 0.0161 | 0.023 | 0.0526 |
Echinococcus multilocularis | Nicastrin | 0.0438 | 0.0739 | 0.0705 |
Trypanosoma brucei | presenilin-like aspartic peptidase, putative | 0.0898 | 0.1584 | 0.4065 |
Trypanosoma cruzi | Aph-1 protein, putative | 0.2135 | 0.3856 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0438 | 0.0739 | 0.0705 |
Trypanosoma cruzi | Nicastrin, putative | 0.0161 | 0.023 | 0.0526 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0365 | 0.0604 | 0.1504 |
Trichomonas vaginalis | Clan AD, family A22, presenilin-like aspartic peptidase | 0.0898 | 0.1584 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0036 | 0.0036 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0192 | 0.0287 | 0.5 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0365 | 0.0604 | 0.1504 |
Echinococcus multilocularis | nicalin | 0.0161 | 0.023 | 0.0195 |
Trypanosoma cruzi | presenilin-like aspartic peptidase, putative | 0.0898 | 0.1584 | 0.4065 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0365 | 0.0604 | 0.1504 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0173 | 0.0251 | 0.0582 |
Echinococcus granulosus | Nicastrin | 0.0438 | 0.0739 | 0.0705 |
Brugia malayi | hypothetical protein | 0.0315 | 0.0512 | 0.0512 |
Echinococcus granulosus | presenilin enhancer 2 | 0.0843 | 0.1483 | 0.1453 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.0199 | 0.0199 |
Echinococcus granulosus | presenilin | 0.0898 | 0.1584 | 0.1554 |
Toxoplasma gondii | hypothetical protein | 0.0315 | 0.0512 | 1 |
Trichomonas vaginalis | Clan AD, family A22, presenilin-like aspartic peptidase | 0.0898 | 0.1584 | 1 |
Brugia malayi | hypothetical protein | 0.0438 | 0.0739 | 0.0739 |
Trichomonas vaginalis | Clan AD, family A22, presenilin-like aspartic peptidase | 0.0898 | 0.1584 | 1 |
Loa Loa (eye worm) | presenilin spe-4 | 0.0315 | 0.0512 | 0.0512 |
Leishmania major | hypothetical protein, conserved | 0.0254 | 0.04 | 0.1117 |
Entamoeba histolytica | presenilin 1 peptidase, putative | 0.0898 | 0.1584 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0192 | 0.0287 | 0.5 |
Echinococcus multilocularis | presenilin enhancer 2 | 0.0843 | 0.1483 | 0.1453 |
Trypanosoma brucei | Presenilin enhancer-2 subunit of gamma secretase, putative | 0.0254 | 0.04 | 0.0971 |
Brugia malayi | Presenilin-like protein At2g29900 | 0.0315 | 0.0512 | 0.0512 |
Trypanosoma brucei | Aph-1 protein, putative | 0.2135 | 0.3856 | 1 |
Brugia malayi | hypothetical protein | 0.0315 | 0.0512 | 0.0512 |
Loa Loa (eye worm) | gamma-secretase subunit pen-2 | 0.0843 | 0.1483 | 0.1483 |
Echinococcus multilocularis | Nicastrin | 0.0438 | 0.0739 | 0.0705 |
Toxoplasma gondii | hypothetical protein | 0.0254 | 0.04 | 0.7619 |
Brugia malayi | gamma-secretase subunit pen-2 | 0.0843 | 0.1483 | 0.1483 |
Loa Loa (eye worm) | hypothetical protein | 0.0438 | 0.0739 | 0.0739 |
Trypanosoma cruzi | Nicastrin, putative | 0.0161 | 0.023 | 0.0526 |
Brugia malayi | hypothetical protein | 0.0315 | 0.0512 | 0.0512 |
Brugia malayi | Presenilin spe-4 | 0.0315 | 0.0512 | 0.0512 |
Echinococcus granulosus | gamma secretase subunit aph 1 | 0.5478 | 1 | 1 |
Schistosoma mansoni | gamma-secretase subunit aph-1 | 0.5478 | 1 | 1 |
Brugia malayi | Presenilin spe-4 | 0.0315 | 0.0512 | 0.0512 |
Leishmania major | mitochondrial DNA polymerase beta | 0.0365 | 0.0604 | 0.2648 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.0199 | 0.0199 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0062 | 0.0049 | 0.0054 |
Trypanosoma cruzi | Aph-1 protein, putative | 0.2135 | 0.3856 | 1 |
Echinococcus multilocularis | gamma secretase subunit aph 1 | 0.5478 | 1 | 1 |
Loa Loa (eye worm) | gamma-secretase subunit aph-1 | 0.5478 | 1 | 1 |
Echinococcus granulosus | nicalin | 0.0161 | 0.023 | 0.0195 |
Brugia malayi | Presenilin family protein | 0.0898 | 0.1584 | 0.1584 |
Brugia malayi | Presenilin spe-4 | 0.0315 | 0.0512 | 0.0512 |
Brugia malayi | hypothetical protein | 0.0438 | 0.0739 | 0.0739 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.0199 | 0.0199 |
Leishmania major | presenilin-like aspartic peptidase, putative,presenilin-like aspartic peptidase, clan AD, family A22A, putative | 0.0898 | 0.1584 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0036 | 0.0036 |
Trypanosoma cruzi | presenilin-like aspartic peptidase, putative | 0.0898 | 0.1584 | 0.4065 |
Echinococcus multilocularis | presenilin | 0.0898 | 0.1584 | 0.1554 |
Trypanosoma brucei | mitochondrial DNA polymerase beta-PAK | 0.0173 | 0.0251 | 0.0582 |
Schistosoma mansoni | subfamily A22A unassigned peptidase (A22 family) | 0.0898 | 0.1584 | 0.1554 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | = 10 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
AC50 (functional) | = 15.84893192 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
AC50 (functional) | = 19.95262315 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
AC50 (functional) | = 31.6227766 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
Inhibition (binding) | = 30.7 % | Inhibition of NorA in Staphylococcus aureus 1199B assessed as reduction in ethidium bromide efflux at 50 uM by fluorimetry after 5 mins | ChEMBL. | 21141825 |
Potency (functional) | 0.1 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 0.7079 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.8913 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 1.8526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.